The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

32 articles for Y Liao


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure activity relationship of pyridoxazinone substituted RHS analogs of oxabicyclooctane-linked 1,5-naphthyridinyl novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-6).EBI
Merck Research Laboratories
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase¿.EBI
Vertex Pharmaceuticals
Polycyclic Polyprenylated Acylphloroglucinol Congeners Possessing Diverse Structures from Hypericum henryi.EBI
Chinese Academy of Sciences
HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase.EBI
Astrazeneca
Identification of potent and novel alpha4beta1 antagonists using in silico screening.EBI
Biogen
Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists.EBI
Emd-Serono Research Institute
New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.EBI
Universita' Di Siena
 
Synthesis and biology of the rigidified glutamate analogue, trans-2-carboxyazetidine-3-acetic acid (t-CAA)EBI
TBA
Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino [2,3-f]quinazolin derivatives as EGFR-TKIs.EBI
Guangxi Minzu University
Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2.EBI
China Pharmaceutical University
Synthesis and evaluation of hydrazinyl-containing pyrrolo[2,3-d]pyrimidine series as potent, selective and oral JAK1 inhibitors for the treatment of rheumatoid arthritis.EBI
Wuxi Apptec (Shanghai) Co.
Design, Synthesis, and Evaluation of a Series of Novel Super Long-Acting DPP-4 Inhibitors for the Treatment of Type 2 Diabetes.EBI
Haisco Pharmaceutical Group
New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.EBI
University of Groningen
Synthesis and in vitro and in vivo functional studies of ortho-substituted phenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635.EBI
University of Groningen
Structure-aided optimization of 3-O-β-chacotriosyl ursolic acid as novel H5N1 entry inhibitors with high selective index.EBI
South China Agricultural University
New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.EBI
University of GöTeborg
Incorporation of privileged structures into 3-O-β-chacotriosyl ursolic acid can enhance inhibiting the entry of the H5N1 virus.EBI
South China Agricultural University
Synthesis and pharmacological evaluation of triflate-substituted analogues of clozapine: identification of a novel atypical neuroleptic.EBI
University of Groningen
Discovery of novel inhibitors of phosphodiesterase 4 with 1-phenyl-3,4-dihydroisoquinoline scaffold: Structure-based drug design and fragment identification.EBI
South China Agricultural University
1,9-seco-Bicyclic Polyprenylated Acylphloroglucinols from Hypericum uralum.EBI
Chinese Academy of Sciences
Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability.EBI
Vertex Pharmaceuticals
Identification of N- and C-3-Modified Laudanosoline Derivatives as Novel Influenza PAEBI
South China Agricultural University
Structure-based design and structure-activity relationships of 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.EBI
South China Agricultural University
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinaseγ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS).EBI
Vertex Pharmaceuticals
Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.EBI
South China Agricultural University
INHIBITORS OF ANTIMOCROBIAL RESISTANCE AND METHOS USING SAMEBDB
Baylor College of Medicine
Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsBDB
Vertex Pharmaceuticals
Substituted pyridine derivatives as SARM1 inhibitorsBDB
Nura Bio
Heterocyclic compounds as immunomodulatorsBDB
Incyte
Benzimidazole compounds and derivatives as EGFR inhibitorsBDB
Boehringer Ingelheim International
Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disordersBDB
Caliper Life Sciences
Identification of a small-molecule inhibitor of DNA topoisomerase II by proteomic profiling.BDB
Riken Advanced Science Institute